Adherence to isoniazid preventive chemotherapy: A prospective community based study

Archives of Disease in Childhood

Volumn 91, Issue 9, 2006, Pages 762-765

  Marais, B J ^a,b   Van Zyl, Susan ^b   Schaaf, H S ^b   Van Aardt, M ^b   Gie, R P ^b   Beyers, N ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ARTICLE; CHILD; CONTROLLED STUDY; DOCUMENTATION; HOUSEHOLD; HUMAN; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; COMMUNITY HEALTH SERVICES; DRUG ADMINISTRATION SCHEDULE; FAMILY HEALTH; FEMALE; HUMANS; INFANT; ISONIAZID; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

EID: 33748471118     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.097220     Document Type: Article

References (28)

1. Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis-a critical review of the pre-chemotherapy literature. Int J Tuberc Lung Dis 2004;8:278-85.
2. Singh M, Mynak ML, Kumar L, et al. Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child 2005;90:624-8.
3. Topley JM, Maher D, Nyong'onya Mbewe L. Transmission of tuberculosis to contacts of sputum positive adults in Malawi. Arch Dis Child 1996;74:140-5.
4. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:392-402.
5. Marais BJ, Gie RP, Schaaf HS, et al. Childhood pulmonary tuberculosis-old wisdom and new challenges. Am J Respir Crit Care Med 2006;173:1078-90.
6. World Health Organization. Tuberculosis in children. In: Treatment of tuberculosis: guidelines for national programmes, 3rd edn. Geneva: WHO, 2003:61-6.
7. Enarson DA, Rieder HL, Arnadottir T, et al. Treating the disease. In: Management of tuberculosis: a guide for low-income countries, 5th edn. Paris: International Union against Tuberculosis and Lung Disease, 2000:11-24.
8. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47.
9. Smieja MJ, Marchettie CA, Cook DJ, et al. Isoniazid for preventing tuberculosis in non-HIV infected persons. The Cochrane Library 1999;(issue4):1-20.
10. International Union against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982;60:555-64.
11. Claessens NJM, Gausi FF, Meijnen S, et al. Screening childhood contacts of patients with smear-positive tuberculosis in Malawi. Int J Tuberc Lung Dis 2002;6:362-4.
12. Van Zyl S, Marais BJ, Hesseling AC, et al. Adherence to antituberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis 2006;10:13-18.
13. Bibi H, Weiler-Ravell D, Shoseyov D, et al. Compliance to treatment of latent tuberculosis infection in a region of Israel. Isr Med Assoc J 2002;4:13-16.
14. Reichler MR, Reves R, Bur S, et al. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. South Med J 2002;95:414-20.
15. Bock CK, Metzger BS, Tapia JR, et al. A tuberculin screening and isoniazid preventive therapy program in an inner-city population. Am J Respir Crit Care Med 1999;159:295-300.
16. Nolan RJ. Childhood tuberculosis in North Carolina: a study of the opportunities for intervention in the transmission of tuberculosis in children. Am J Public Health 1986;76:26-30.
17. Verver S, Warren RM, Munch Z, et al. Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 2004;363:212-14.
18. Department of Health, South Africa. National Tuberculosis Control Programme, 2000.
19. Seth V, Singhal PK, Semwal OP, et al. Childhood tuberculosis in a referral center: clinical profile and risk factors. Indian Pediatr 1993;30:479-85.
20. Schaaf HS, Michaelis IA, Richardson M, et al. Adult-to-child transmission of tuberculosis: household or community contact? Int J Tuberc Lung Dis 2003;7:426-31.
21. Ena J, Valls V. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 2005;40:670-6.
22. Spyridis N, Tsolia M, Gelesme A, et al. Treatment of latent tuberculosis infection in children and adolescents: a ten year randomized prospective study comparing monotherapy to short course regimens. Int J Tuberc Lung Dis 2005;9(suppl 1):S237.
23. Iseman MD. Less is more: short-course preventive therapy of tuberculosis. Am Rev Respir Dis 1989;140:1187.
24. Lecour HF, Truffot-pernot C, Grosset JH. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide. Am Rev Respir Dis 1989;140:1189-93.
25. Priest DH, Vossel LF, Sherfy EA, et al. Use of intermittent rifampin and pyrazinamide therapy for tuberculosis infection in a targeted tuberculin-testing program. Clin Infect Dis 2004;15:1764-71.
26. Magdorf K, Arizzi Rusche AF, Geiter RJ, et al. Short-course preventive therapy for tuberculosis: a pilot study of rifampin and rifampin-pyrazinamide regimens in children. Am Rev Respir Dis 1991;143(suppl):A120.
27. Schaaf HS, Marais BJ, Hesseling AC, et al. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr 2006;95:523-8.
28. Donald PR. Preventing tuberculosis in childhood. Indian J Pediatr 2000;67:383-5.